Please use this identifier to cite or link to this item:
https://scholarbank.nus.edu.sg/handle/10635/109338
Title: | Expression of urocortin 2 and its inhibitory effects on intracellular Ca2+ via L-type voltage-gated calcium channels in rat pheochromocytoma (PC12) cells | Authors: | Tao, J. Zhang, Y. Soong, T.W. Li, S. |
Keywords: | Intracellular Ca2+ concentration ([Ca2+] i) PC12 cells Urocortin 2 Voltage-gated calcium channel (VGCC) Whole-cell patch clamp |
Issue Date: | 4-Dec-2006 | Citation: | Tao, J., Zhang, Y., Soong, T.W., Li, S. (2006-12-04). Expression of urocortin 2 and its inhibitory effects on intracellular Ca2+ via L-type voltage-gated calcium channels in rat pheochromocytoma (PC12) cells. Neuropsychopharmacology 31 (12) : 2600-2609. ScholarBank@NUS Repository. | Abstract: | Urocortin 2, a new member of the corticotrophin-releasing factor (CRF) neuropeptide family, was reported to be widely expressed in the central nervous system and peripheral tissues. Here, we detected urocortin 2 mRNA in PC12 cells using reverse transcription-polymerase chain reaction (RT-PCR). Furthermore, we observed its effects on intracellular Ca2+ concentration ([Ca 2+]i) using confocal microscopy and flow cytometry and on voltage-gated calcium channel (VGCC) currents using whole-cell patch clamp. Our results showed that urocortin 2 mRNA was coexpressed with CRF, and CRF receptor (CRFR) 2β in undifferentiated PC12 cells, but not CRFR1 or CRFR2α. KCl (40 mM) or Bay K8644 (1 μM), an L-type VGCC activator, increased [Ca 2+]i. Pretreatment of the cells with urocortin 2 significantly diminished the effect of Bay K8644 or KCl. Urocortin 2 showed no influence on [Ca2+]i in tyrode's solution containing EGTA or Ca2+-free tyrode's solution. It reversibly inhibited the VGCC currents in a concentration-dependent manner, but had no apparent effects on the cells treated with nifedipine (1 μM), an L-type VGCC blocker. Urocortin 2 up-shifted the current-voltage curves. No frequency-dependence of urocortin 2 effects on IBa was observed. The inhibitory effects of urocortin 2 on VGCC currents or [Ca2+]i were not affected by astressin 2B, an antagonist of CRFR2. As calcium overload play a key role in some neuronal degenerative diseases such as Alzheimer's and Parkinson's diseases, our results suggest that urocortin 2 may be a potentially interesting agent for the treatment of these diseases. © 2006 Nature Publishing Group All rights reserved. | Source Title: | Neuropsychopharmacology | URI: | http://scholarbank.nus.edu.sg/handle/10635/109338 | ISSN: | 0893133X |
Appears in Collections: | Staff Publications |
Show full item record
Files in This Item:
There are no files associated with this item.
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.